Evidence map›Paper›PMID 34133066›Full record

ArticleHemodialysis international. International Symposium on Home Hemodialysis2021

Cognitive impairment in a patient with COVID-19 on hemodialysis: Too dangerous to neglect!

Lucas M Jacobs, Marie Dominique Gazagnes, Said Sanoussi, Frederic Collart, Maria do Carmo F Mesquita

Open access · bronzeAbstract readCase Reports
In one paragraph

Article in Hemodialysis international. International Symposium on Home Hemodialysis, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Review
  3. Cognitive impairment in a patient with COVID-19 on hemodialysis: Too dangerous to neglect!Hemodialysis international. International Symposium on Home Hemodialysis · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Lucas M JacobsClinique de Nephrology, Department of Internal Medecine, CHU Brugmann, Université Libre de Brussels, Brussels, Belgium.
Marie Dominique GazagnesNeurology Department, CHU Brugmann, Université Libre de Brussels, Brussels, Belgium.
Said SanoussiRadiology Department, CHU Brugmann, Université Libre de Brussels, Brussels, Belgium.
Frederic CollartClinique de Nephrology, Department of Internal Medecine, CHU Brugmann, Université Libre de Brussels, Brussels, Belgium.
Maria do Carmo F MesquitaClinique de Nephrology, Department of Internal Medecine, CHU Brugmann, Université Libre de Brussels, Brussels, Belgium.
Centre Hospitalier Universitaire Brugmann · BEUniversité Libre de Bruxelles · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neurological manifestations of coronavirus disease 2019 (COVID-19) often have tragic repercussions. Although many reports of neurological complications of severe acute respiratory syndrome coronavirus 2 infection exist, none of them are of patients on hemodialysis, who have a fivefold greater risk of stroke than the general population. In this report, we emphasize the importance of being vigilant for mild stroke in high risk populations-such as patients on hemodialysis-with COVID-19, since these conditions have overlapping symptoms.

Indexed as

Cognitive DysfunctionCOVID-19Nervous System DiseasesHumansRenal DialysisSARS-CoV-2cognitive impairmentCOVID-19encephalopathyhemodialysisischemic stroke

Identifiers

PMID34133066
PMCPMC8444690
OpenAlexW3169834057

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.